Daniel A. Engel

1.2k total citations
36 papers, 1.0k citations indexed

About

Daniel A. Engel is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Daniel A. Engel has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Epidemiology and 10 papers in Genetics. Recurrent topics in Daniel A. Engel's work include interferon and immune responses (9 papers), Virus-based gene therapy research (9 papers) and Influenza Virus Research Studies (6 papers). Daniel A. Engel is often cited by papers focused on interferon and immune responses (9 papers), Virus-based gene therapy research (9 papers) and Influenza Virus Research Studies (6 papers). Daniel A. Engel collaborates with scholars based in United States, Germany and Switzerland. Daniel A. Engel's co-authors include Daniel J. Murphy, Stephen Hardy, Dipanwita Basu, Núria Morral, Marcin P. Walkiewicz, Jeffrey S. Johnson, Ralph S. Baric, Matthew B. Frieman, Jiangning Chen and Péter Lengyel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Daniel A. Engel

35 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel A. Engel United States 19 647 283 211 209 189 36 1.0k
Mark Kokoris United States 14 595 0.9× 466 1.6× 268 1.3× 67 0.3× 142 0.8× 17 1.1k
Kazuyuki Takai Japan 21 1.3k 2.0× 204 0.7× 112 0.5× 110 0.5× 102 0.5× 103 1.6k
A Roseto France 19 439 0.7× 96 0.3× 121 0.6× 192 0.9× 125 0.7× 59 834
Brett D. Welch United States 15 667 1.0× 120 0.4× 386 1.8× 140 0.7× 379 2.0× 18 1.3k
Vladimir Presnyak United States 16 1.8k 2.9× 317 1.1× 289 1.4× 196 0.9× 243 1.3× 19 2.2k
Sai Vikram Vemula United States 15 367 0.6× 151 0.5× 391 1.9× 120 0.6× 277 1.5× 29 960
Christine L. Hatem United States 14 430 0.7× 234 0.8× 322 1.5× 181 0.9× 252 1.3× 21 1.0k
Tokuichi Kawaguchi Japan 15 311 0.5× 102 0.4× 173 0.8× 98 0.5× 86 0.5× 22 799
Pappanaicken R. Kumaresan United States 18 350 0.5× 76 0.3× 213 1.0× 472 2.3× 166 0.9× 57 1.2k
Suzane Ramos da Silva United States 18 423 0.7× 71 0.3× 318 1.5× 130 0.6× 174 0.9× 30 1.0k

Countries citing papers authored by Daniel A. Engel

Since Specialization
Citations

This map shows the geographic impact of Daniel A. Engel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Engel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Engel more than expected).

Fields of papers citing papers by Daniel A. Engel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Engel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Engel. The network helps show where Daniel A. Engel may publish in the future.

Co-authorship network of co-authors of Daniel A. Engel

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Engel. A scholar is included among the top collaborators of Daniel A. Engel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Engel. Daniel A. Engel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romanovski, Valentin, Elena Romanovskaia, Carol Frances Glover, et al.. (2025). Cu and Cu‐30Ni Alloy as Anti‐Viral Materials for High‐Touch Surfaces: Efficacy in a Simulated Public Environment with Frequent Cleaning Practices. Advanced Materials Interfaces. 12(22). 1 indexed citations
2.
Miyake, Tsuyoshi, et al.. (2025). Co-option of mitochondrial nucleic acid–sensing pathways by HSV-1 UL12.5 for reactivation from latent infection. Proceedings of the National Academy of Sciences. 122(4). e2413965122–e2413965122. 2 indexed citations
3.
Patnaik, Samarjit, Dipanwita Basu, Noel Southall, et al.. (2019). Identification, design and synthesis of novel pyrazolopyridine influenza virus nonstructural protein 1 antagonists. Bioorganic & Medicinal Chemistry Letters. 29(9). 1113–1119. 13 indexed citations
4.
Davydova, Elena K., Urszula Derewenda, Tsuyoshi Miyake, et al.. (2018). The structure of the C-terminal domain of the nucleoprotein from the Bundibugyo strain of the Ebola virus in complex with a pan-specific synthetic Fab. Acta Crystallographica Section D Structural Biology. 74(7). 681–689. 7 indexed citations
5.
Derewenda, Urszula, et al.. (2017). Crystal structures of the methyltransferase and helicase from the ZIKA 1947 MR766 Uganda strain. Acta Crystallographica Section D Structural Biology. 73(9). 767–774. 8 indexed citations
6.
Patnaik, Samarjit, Dipanwita Basu, Seameen Dehdashti, et al.. (2013). Discovery of Small Molecule Influenza Virus NS1 Antagonist. Europe PMC (PubMed Central). 2 indexed citations
7.
Engel, Daniel A.. (2013). The influenza virus NS1 protein as a therapeutic target. Antiviral Research. 99(3). 409–416. 54 indexed citations
8.
Spoerner, Michael, et al.. (2012). Metal–Bis(2‐picolyl)amine Complexes as State 1(T) Inhibitors of Activated Ras Protein. Angewandte Chemie International Edition. 51(42). 10647–10651. 61 indexed citations
9.
Schaack, Jerome, Liping Qiao, Marcin P. Walkiewicz, et al.. (2011). Insertion of CTCF-binding sites into a first-generation adenovirus vector reduces the innate inflammatory response and prolongs transgene expression. Virology. 412(1). 136–145. 3 indexed citations
10.
Engel, Daniel A., et al.. (2011). Design, synthesis, and evaluation of novel small molecule inhibitors of the influenza virus protein NS1. Bioorganic & Medicinal Chemistry. 20(1). 487–497. 36 indexed citations
11.
Frieman, Matthew B., Dipanwita Basu, Krystal Matthews, et al.. (2011). Yeast Based Small Molecule Screen for Inhibitors of SARS-CoV. PLoS ONE. 6(12). e28479–e28479. 34 indexed citations
12.
13.
Walkiewicz, Marcin P., Núria Morral, & Daniel A. Engel. (2009). Accurate single-day titration of adenovirus vectors based on equivalence of protein VII nuclear dots and infectious particles. Journal of Virological Methods. 159(2). 251–258. 18 indexed citations
14.
Chen, Jiangning, Núria Morral, & Daniel A. Engel. (2007). Transcription releases protein VII from adenovirus chromatin. Virology. 369(2). 411–422. 48 indexed citations
15.
Spector, David J., Jeffrey S. Johnson, Nicholas L. Baird, & Daniel A. Engel. (2003). Adenovirus type 5 DNA–protein complexes from formaldehyde cross-linked cells early after infection. Virology. 312(1). 204–212. 10 indexed citations
16.
Engel, Daniel A., et al.. (2002). Conforto ambiental em salas de aula do CEFET-PR. 16. 24–42.
17.
Kulesza, Caroline, et al.. (2002). Adenovirus E1A requires the yeast SAGA histone acetyltransferase complex and associates with SAGA components Gcn5 and Tra1. Oncogene. 21(9). 1411–1422. 26 indexed citations
18.
Miller, Mary, Bradley R. Cairns, Randy Levinson, et al.. (1996). Adenovirus E1A Specifically Blocks SWI/SNF-Dependent Transcriptional Activation. Molecular and Cellular Biology. 16(10). 5737–5743. 27 indexed citations
19.
Engel, Daniel A., Jay Snoddy, Elena Toniato, & Péter Lengyel. (1988). Interferons as gene activators: Close linkage of two interferon-activatable murine genes. Virology. 166(1). 24–29. 24 indexed citations
20.
Samanta, Himadri & Daniel A. Engel. (1987). Deionization of formamide with Biorad AG501-X(D). Journal of Biochemical and Biophysical Methods. 14(5). 261–266. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Kokoris Breakdown of academic impact, for papers by Kazuyuki Takai Breakdown of academic impact, for papers by A Roseto Breakdown of academic impact, for papers by Brett D. Welch Breakdown of academic impact, for papers by Vladimir Presnyak Breakdown of academic impact, for papers by Sai Vikram Vemula Breakdown of academic impact, for papers by Christine L. Hatem Breakdown of academic impact, for papers by Tokuichi Kawaguchi Breakdown of academic impact, for papers by Pappanaicken R. Kumaresan Breakdown of academic impact, for papers by Suzane Ramos da Silva
Rankless by CCL
2026